ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 98 filers reported holding ATRECA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q1 2023 | $17,252 | +42.2% | 15,133 | -0.2% | 0.00% | – |
Q4 2022 | $12,135 | -56.7% | 15,169 | -14.5% | 0.00% | – |
Q3 2022 | $28,000 | -48.1% | 17,738 | -40.8% | 0.00% | – |
Q2 2022 | $54,000 | -82.5% | 29,954 | -69.2% | 0.00% | – |
Q1 2022 | $309,000 | -22.6% | 97,411 | -26.2% | 0.00% | – |
Q4 2021 | $399,000 | +96.6% | 131,942 | +305.6% | 0.00% | – |
Q3 2021 | $203,000 | -50.1% | 32,531 | -31.8% | 0.00% | – |
Q2 2021 | $407,000 | +42.3% | 47,667 | +155.2% | 0.00% | – |
Q1 2021 | $286,000 | +49.0% | 18,676 | +57.2% | 0.00% | – |
Q4 2020 | $192,000 | +14.3% | 11,879 | -0.9% | 0.00% | – |
Q3 2020 | $168,000 | -37.1% | 11,984 | -4.4% | 0.00% | – |
Q2 2020 | $267,000 | +281.4% | 12,541 | +194.9% | 0.00% | – |
Q1 2020 | $70,000 | -16.7% | 4,252 | -21.9% | 0.00% | – |
Q4 2019 | $84,000 | +162.5% | 5,443 | +104.9% | 0.00% | – |
Q3 2019 | $32,000 | – | 2,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
CM Management, LLC | 60,000 | $969,000 | 0.90% |
Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |